Low-Level Fluoroquinolone Resistance among Campylobacter jejuni Isolates in Australia

Abstract

The very low level of ciprofloxacin resistance in C. jejuni isolates likely reflects the success of Australia's policy of restricting use of fluoroquinolones in food-producing animals.

Industrial Food Animal Production, Antimicrobial Resistance, and Human Health

“…Similar data were found in studies of isolates from poultry and humans in Norway (50) and in the Netherlands (15). In contrast, the relatively low rate of fluoroquinolone resistance in clinical isolates in Australia has been attributed to the fact that this drug was never used in agriculture (81).…”

Re-analysis of the risks attributed to ciprofloxacin-resistant Campylobacter jejuni infections

“…In addition, smallerscale studies are available from Australia, Denmark and the USA [21][22][23]. The available literature presents conflicting findings.…”

Antibiotic Resistance of Campylobacter jejuni and Campylobacter coli Clinical Isolates from Poland

“…The relatively high fluoroquinolone resistance rates among Campylobacter isolates are most probably caused by the broad use of this class of antibiotics in veterinary medicine (especially in poultry) (10). This hypothesis is supported by the very low (2%) frequency of ciprofloxacin-resistant clinical isolates of C. jejuni observed in Australia, where the usage of fluoroquinolones in food-producing animals is prohibited (18). In Poland, such restriction was introduced in 2006, but fluoroquinolones are still allowed in veterinary medicine.…”